New study checks Long-Term safety of arthritis drug in kids

NCT ID NCT06751238

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times

Summary

This study looks at how the body processes secukinumab given through an IV in children aged 2 to 17 with juvenile psoriatic arthritis. Researchers will measure drug levels in the blood and monitor side effects over up to 6 years. The goal is to understand the drug's safety and how it works in young patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JUVENILE PSORIATIC ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Ann and Robert H Lurie Childs Hosp

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Cincinnati Childrens Hospital

    RECRUITING

    Cincinnati, Ohio, 45229, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Legacy Emanuel Research Hosp Portland

    RECRUITING

    Portland, Oregon, 97232, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Levine Childrens Hospital

    RECRUITING

    Charlotte, North Carolina, 28203, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Texas Arthritis Center

    RECRUITING

    El Paso, Texas, 79902, United States

    Contact Email: •••••@•••••

    Contact

  • Univ Hosp Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106-5028, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Florida

    RECRUITING

    Gainesville, Florida, 32610 8068, United States

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.